Budget 2024: Pharma sector seeks tax sops, effective intellectual property rights regime

Union Budget: Outlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai urged the government to explore methods to incentivise R&D investments, such as deductions on R&D expenses, research-linked incentives for MNCs, and corporate tax concessions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wVlRUab
via IFTTT